MLTX Enters $0 Master Commercial Supply Agreement with Vetter Pharma, Secures Manufacturing Capacity for Sonelokimab
MoonLake Immunotherapeutics Class A Ordinary Shares · PHARMACEUTICAL PREPARATIONS · Now $18.82
-0.0% in 1h after detection
Post-detection moves
1h
-0.0%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS